• Explore /
  • Poster
  • / Impact of renal impairment on clinical outcomes in patients (pts) with locally advanced or metastatic (LA/M) urinary tract carcinoma (UTC) treated with atezolizumab (atezo): Analysis of the international SAUL study.

Impact of renal impairment on clinical outcomes in patients (pts) with locally advanced or metastatic (LA/M) urinary tract carcinoma (UTC) treated with atezolizumab (atezo): Analysis of the international SAUL study.

Abstract Video & Slides Poster

Authors

null

Margitta Retz

Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany

Margitta Retz , Florian Seseke , Giuseppe Luigi Banna , Ugo De Giorgi , Thomas Powles , Umberto Basso , Raymond S. McDermott , Anna Llado , Wen-Pin Su , Cristina Ligia Cebotaru , Javier Puente , Alvaro Montesa , Jacques De Greve , Zsuzsanna Kahan , Urbano Anido Herranz , Sabine de Ducla , Julie Pavlova , Simon Fear , Cora N. Sternberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT02928406

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5036)

DOI

10.1200/JCO.2020.38.15_suppl.5036

Abstract #

5036

Poster Bd #

105

Abstract Disclosures

Similar Posters

First Author: Jens Bedke

First Author: Petros Grivas

First Author: Roberto Iacovelli

First Author: Cora N. Sternberg